Key result
Subclinical atrial fibrillation detected by cardiac electronic devices has an incidence of approximately 30% and increases embolic risk, guiding individualized anticoagulant prophylaxis.
Why the study?
Does oral anticoagulant treatment prevent stroke and systemic embolism in patients with subclinical atrial fibrillation?
Does oral anticoagulant treatment prevent stroke and systemic embolism in patients with subclinical atrial fibrillation?
Anticoagulation for subclinical atrial fibrillation should be individualized based on arrhythmic burden and CHA₂DS₂-VASc score to prevent stroke.
No abstract yet. The journal hasn't published one we can show.
No takes yet. Share an insight, caveat, or question.
L Gherasim (2018) conducted an editorial in Subclinical Atrial Fibrillation. Oral Anticoagulants was evaluated. Subclinical atrial fibrillation detected by cardiac electronic devices has an incidence of approximately 30% and increases embolic risk, guiding individualized anticoagulant prophylaxis.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: